Human Genome Project Information. Click to return to home page.

Sponsored by the U.S. Department of Energy Human Genome Program

Human Genome News Archive Edition
  Vol.10, No.1-2   February 1999
Available in PDF 
In this issue... 

Genome Project 

In the News 

Microbial Genomics 

Ethical, Legal, and Social Issues and Educational Resources 


Genetics in Medicine 


Web, Other Resources, Publications 


Meeting Calendars & Acronyms 

  • Genome and Biotechnology Meetings 
  • Training Courses and Workshops 
  • Acronyms 

HGN archives and subscriptions 
HGP Information home

Second Private Human Genome Sequencing Project Under Way

In August 1998, Incyte Pharmaceuticals Inc. of Palo Alto, California, announced plans to spend $200 million over the next 2 years to sequence human genes in its new unit, Incyte Genetics. Incyte also stated that it would acquire Hexagen Inc. (Cambridge, U.K.), which has developed a proprietary technique for identifying genetic variations in mice.

Incyte Genetics will concentrate on cataloguing SNPs. Using this knowledge to design drugs --an application of genetic data known as pharmacogenetics-- may help companies produce more effective therapeutics. The pace of development may be accelerated by genetically prescreening for appropriate participants in clinical trials.

The announcement came 3 months after another private company was formed for human genome sequencing. Celera Genomics, established by researcher J. Craig Venter (formerly president of The Institute for Genome Research) and Perkin-Elmer's Applied Biosystems Division, also is expected to focus on genes and their sequence variations [HGN9(3),1]

In contrast to the emphasis on identifying genes by these private companies, the sequence produced by the government-backed Human Genome Project (HGP) will reflect the entire, 3-billion-base human genome. Obtaining the complete reference human genome sequence will enable scientists to begin exploring the function of genes as well as important extragenic regions and their roles in human health and disease. The HGP also is funding the creation of clone resources for mapping and sequencing, bioinformatics and comparative genomics infrastructure, and next-generation sequencing technologies (see new goals).

All HGP data is freely accessible over the Internet and released daily for immediate use by scientists throughout the world. Celera plans to release data freely to the research community on a quarterly basis, and Incyte data will be available for a fee.

The electronic form of the newsletter may be cited in the following style:
Human Genome Program, U.S. Department of Energy, Human Genome News (v10n1-2).

Return to Top of Page

Acronym List

Human Genome Project 1990–2003

The Human Genome Project (HGP) was an international 13-year effort, 1990 to 2003. Primary goals were to discover the complete set of human genes and make them accessible for further biological study, and determine the complete sequence of DNA bases in the human genome. See Timeline for more HGP history.

Human Genome News

Published from 1989 until 2002, this newsletter facilitated HGP communication, helped prevent duplication of research effort, and informed persons interested in genome research.